Chemoradiotherapy, the simultaneous delivery of chemotherapy and radiation, has become a cornerstone treatment for locally advanced oropharyngeal tumors, which arise in the tonsils, base of tongue, and surrounding throat tissues. The approach can be organ-preserving and highly effective at controlling disease, but it comes at a physiological cost. Radiation fields inevitably overlap with muscles, nerves, and mucosal surfaces that orchestrate the deceptively complex act of swallowing, a behavior that requires more than thirty paired muscles to contract in precise sequence within roughly one second. Fibrosis, neuromuscular damage, and loss of salivary function can leave survivors with a throat that moves stiffly and inefficiently, sometimes for the rest of their lives. Previous research has linked severe dysphagia in head and neck cancer patients not only to malnutrition and social isolation but also to worse survival itself, making the problem far more than a comfort issue.

To capture the true scope of the problem, the Portuguese team deployed two fundamentally different kinds of measurement. The first was flexible endoscopic evaluation of swallowing, or FEES, an instrumental technique in which a thin endoscope is passed through the nose to the pharynx, allowing clinicians to watch swallowing physiology directly and in real time. FEES reveals objective phenomena: whether food or liquid penetrates the laryngeal vestibule, whether material is aspirated below the vocal folds, how much residue coats the pharyngeal walls after each swallow, and how many repeat swallows a patient needs to clear a bolus of solid food. The second approach relied on patient-reported outcome measures, or PROMs, using three validated questionnaires: the EORTC QLQ-C30, a general cancer quality-of-life instrument; the EORTC QLQ-H&N43, a head-and-neck-specific module; and the SWAL-QOL, a dedicated swallowing quality-of-life tool that probes the burden dysphagia places on eating, social life, and emotional wellbeing.

The instrumental findings were sobering. FEES identified frequent swallowing impairments across the cohort, with pharyngeal residue emerging as a particularly dominant problem. In practical terms, after each swallow, food particles and liquid remained coating the throat rather than being cleared into the esophagus, a phenomenon that is not merely uncomfortable but dangerous, because residue can slip into the airway after the swallow is over, in what clinicians call post-swallow aspiration. The endoscopic evaluations also documented an increased number of swallows required to clear solid consistencies, reflecting reduced swallowing efficiency, as well as penetration-aspiration events in which material entered or passed below the level of the larynx. These are the classic physiological signatures of radiation-induced pharyngeal dysfunction, and their frequency in disease-free survivors underscores how durable the damage can be long after treatment ends.

The questionnaire data told an equally important story from the patient’s side of the experience. All three instruments revealed substantial dysphagia-related burden, but the SWAL-QOL stood out by identifying the highest proportion of altered results among the survivors. This finding makes intuitive sense once the tool’s design is considered: because SWAL-QOL was built specifically to measure the consequences of oropharyngeal dysphagia, it asks about domains the generic cancer instruments barely touch, including the fear of choking, the embarrassment of eating in public, the fatigue of prolonged meals, and the loss of pleasure associated with food. For survivors whose tumors originated in the very structures used for eating and speaking, these dimensions are not peripheral; they define daily life. A survivor who can technically swallow but dreads every meal carries a burden that a clinical chart may never record.

Perhaps the most scientifically consequential result of the study lies in what the researchers did not find. When they explored the associations between objective FEES findings and the quality-of-life domains captured by the questionnaires, using correlation and comparative analyses, they observed some connections between the two worlds. Yet no consistent one-to-one relationship emerged between physiological impairment and patient-reported burden. In other words, a survivor whose endoscopy shows significant residue or aspiration may report only modest distress, while another with comparatively subtle physiological findings may describe a devastating impact on eating and social functioning. This decoupling of mechanism from experience is not a flaw in either measurement approach; it is a fundamental property of how chronic illness is lived, shaped by adaptation, compensation, expectations, and psychological resilience.

The study’s authors frame this as evidence that FEES and PROMs capture complementary dimensions of dysphagia rather than redundant ones. FEES maps the biomechanics: the safety of the swallow, its efficiency, and the temporal physiology of the pharyngeal phase. PROMs map the functional and psychosocial fallout: whether the patient can enjoy a restaurant meal, maintain weight, and feel like a full participant in family life. Neither alone provides a complete clinical picture. A follow-up program built solely on instrumental assessments risks dismissing patients whose suffering is real but invisible to the endoscope, while a program built solely on questionnaires risks missing silent aspiration, the dangerous scenario in which material enters the airway without triggering any cough or sensation, quietly predisposing patients to pneumonia.

These findings arrive amid a broader shift in oncology toward routine collection of patient-reported outcomes during and after treatment. Systematic reviews have identified PROMs as valuable tools for surveillance of physical and emotional symptoms in head and neck cancer populations, and prior studies have repeatedly noted that patient-assessed symptoms can be poor predictors of objective findings in irradiated pharyngeal cancer patients. The Portuguese study adds weight to this literature by demonstrating the same discordance in a carefully defined group: disease-free survivors, assessed with a validated Portuguese version of SWAL-QOL, paired with structured endoscopic evaluation. The convergence of independent lines of evidence strengthens the argument that dual assessment should become standard practice rather than an optional refinement.

The clinical implications are concrete. For survivors of oropharyngeal cancer treated with chemoradiotherapy, long-term follow-up should ideally combine periodic instrumental swallowing evaluation with validated questionnaires, so that rehabilitation can be targeted to the specific physiology found on FEES while counseling and psychosocial support are guided by what patients actually report. Swallowing therapy, dietary modification, and prophylactic exercise programs exist and can help, but they can only be deployed rationally when the full picture of a patient’s dysfunction is known. The study’s cross-sectional design, with 38 participants, means the findings describe a snapshot rather than a trajectory, and the authors themselves position the work as exploratory; larger longitudinal studies will be needed to track how the relationship between physiology and perception evolves over the years after treatment.

Still, the central message resonates far beyond this single cohort. Modern cancer medicine has become extraordinarily good at measuring tumors, but measuring the aftermath of cure remains an inexact science. For the growing population of oropharyngeal cancer survivors, many of them relatively young and facing decades of life after treatment, the difference between a cure and a good life often comes down to functions as mundane and as profound as swallowing a meal without fear. This study reminds clinicians, researchers, and patients alike that the throat seen through an endoscope and the meal experienced at a family table are two different territories, and that good survivorship care requires a map of both.

Subject of Research: Swallowing dysfunction and quality of life in oropharyngeal cancer survivors after chemoradiotherapy

Article Title: Patient-reported swallowing burden and FEES findings in disease-free oropharyngeal cancer survivors after chemoradiotherapy

Article References: Vieira, D. O., Barreira, S., Dinis-Ribeiro, M., & Monteiro, E. (2026). Patient-reported swallowing burden and FEES findings in disease-free oropharyngeal cancer survivors after chemoradiotherapy. Supportive Care in Cancer, 34(10), Article 1071. https://doi.org/10.1007/s00520-026-11307-4

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11307-4

Keywords: oropharyngeal cancer, dysphagia, chemoradiotherapy, FEES, patient-reported outcomes, SWAL-QOL, quality of life, head and neck cancer, supportive care, cancer survivorship, swallowing rehabilitation, EORTC questionnaires

The research, led by Astrid Machielsen of Catharina Hospital Eindhoven and colleagues across multiple Dutch centers, was conducted between December 2021 and March 2024 and followed a rigorous three-step methodology aligned with the COMET Initiative, the international standard for core outcome set development. First, the team performed a systematic literature review of studies published between 2010 and 2021 to catalog the questionnaires already in use. That search identified 301 records, of which 46 articles met eligibility criteria, and revealed a fragmented measurement landscape: 46 different questionnaires had been deployed to assess quality of life, with the Female Sexual Function Index and the EORTC QLQ-C30 each appearing in ten studies, followed by the FACT-V, FACT-G, and SF-12. No single instrument, and no agreed set of outcomes, dominated the field.

The second step brought patients, partners, and healthcare professionals directly into the process. The researchers conducted 28 semi-structured telephone interviews with ten patients treated for vulvar cancer within the previous two years, eight partners, and ten healthcare professionals including gynecologic oncologists, radiation therapists, oncologists, plastic surgeons, and physician assistants. Interviewers, who had no prior clinical relationship with participants to reduce bias, presented established questionnaires and probed for what was missing. The conversations surfaced concepts that standard instruments had never captured: the ability to cycle or wear tight clothing, feelings of comfort looking at and touching one’s own genital area, vaginal odor, changes in genital sensation, and the impact of surgery on entering new relationships. From these interviews, the team extracted 55 patient outcomes and 23 partner outcomes to carry forward.

The third and decisive step was a two-round online Delphi study, run between March and November 2023 using DelphiManager software developed by the COMET Initiative. Seventy participants registered for the first round: 34 patients, 12 partners, and 24 healthcare professionals. Each participant rated the importance of every outcome on a ten-point Likert scale, with consensus criteria defined in advance. An outcome was deemed ‘consensus in’ if at least 70 percent of participants scored it as very important, between 7 and 10, and fewer than 15 percent scored it as not important, between 1 and 3. Outcomes failing to reach agreement in round one were re-presented in round two alongside an anonymized graphical summary of how the other groups had rated them, allowing participants to revise their own scores in light of the collective view.

The patient Delphi proved rich and revealing. Of the 55 outcomes presented in the first round, 28 achieved consensus in, five were voted out, and 22 remained contested, with disagreement concentrated in the domains of sexual functioning and delivery of care. Participants also proposed four new outcomes: removal of part of the clitoris, vaginal odor, change in genital sensation, and the impact on entering new relationships. After the second round and a final online consensus meeting attended by eight patients and five healthcare professionals, the researchers consolidated four overlapping fear-of-recurrence items into a single outcome and settled on a final patient-centered core outcome set of 45 outcomes. These span physiological functioning and physical symptoms, physical, sexual, and emotional functioning, global quality of life, and information provision.

Notably, the set includes outcomes that are rarely measured in cancer research generally: wound healing, body image, and fear of recurrence. During the consensus meeting, patients explained that lichen sclerosus, a chronic inflammatory skin condition, is intertwined with their fear that symptoms signal returning cancer, and that the inability to wear tight clothes after surgery carries a persistent sense of embarrassment, particularly when complicated by visible lymphedema. Patients also clarified that while sexuality matters deeply, detailed discussions are not always wanted at every visit; instead, the topic should be revisited periodically, because needs change over time. Communication about sexuality, they emphasized, should extend beyond partners to include healthcare professionals themselves.

The partner results were unexpectedly spare. The partner Delphi began with 23 outcomes, but after two rounds and a planned consensus meeting that was canceled due to low participation, the final partner-centered set contained just six outcomes, all related to information provision rather than partners’ own quality of life. Partners repeatedly affirmed that the patient should be the primary focus of care, and the majority of healthcare professionals agreed, with some cautioning that formally assessing partner well-being could raise expectations of treating the partner as a patient. Partners did describe real worries, including concern about their partner’s sexual pleasure and fear of hurting them during sexual activity, but they saw an additional questionnaire during aftercare as offering limited value. The researchers concluded that a full partner-centered outcome set is unnecessary, and that the six information-related outcomes can be assessed with the EORTC QLQ-INFO25.

A crucial practical contribution of the study is its mapping of the 45 patient outcomes onto existing validated instruments. The researchers recommend a combination of scales and items from the EORTC QLQ-C30, the vulvar cancer module QLQ-VU34, the sexual health module SH22, and INFO25, together with the FACT-V and the WOUND-Q, which covers wound-related outcomes. Because all EORTC questionnaires share a similar answering format, assembling them into a coherent assessment is feasible. Some outcomes still lack any dedicated measure, including cycling, wearing clothes, feeling comfortable with the genital area, intimacy, and the impact of wounds on quality of life. For these, the team identified partial solutions from the EORTC item bank, such as item Q273 for tight clothing and item Q364 or the Fear of Cancer Recurrence Inventory for lichen sclerosus-related fear, and recommended the Maudsley Marital Questionnaire where deeper exploration of the patient-partner interaction is needed.

The authors are candid about the limitations. Vulvar cancer’s low incidence constrained the sample size, and the Delphi process, though iterative and inclusive, suffered attrition of roughly 20 to 25 percent between rounds, which may have narrowed the diversity of perspectives. No single comprehensive questionnaire yet exists that captures all 45 outcomes, meaning clinics must combine instruments. The EORTC QLQ-VU34, while promising, is still in phase four of development and validation and was designed for clinical trials rather than routine care. These caveats notwithstanding, the adherence to COMET guidance, the anonymity of Delphi ratings, and the mixed-methods foundation of literature review plus qualitative interviews give the findings substantial credibility and reproducibility.

The implications reach well beyond the Netherlands. By defining, from the patient’s own vantage point, what quality of life after vulvar cancer surgery actually consists of, the study gives trialists a common language for comparing interventions, reduces reporting bias, and gives clinicians a concrete checklist for aftercare conversations that too often skip sexuality, body image, and fear of recurrence. Patient-reported outcome measures have previously been linked to improved symptom management, particularly when results are discussed with patients, and this core outcome set provides the framework for doing so systematically. The next step is already underway: the outcome set will be integrated into the IMPACT-V project, a Dutch quality improvement initiative for vulvar cancer care, where it will enable ongoing evaluation of whether daily clinical practice becomes genuinely responsive to the outcomes patients themselves have declared most important.

Subject of Research: Development of a patient-centered core outcome set for health-related quality of life after vulvar cancer surgery using a Delphi consensus method

Article Title: Determining core quality of life outcomes for patients with vulvar cancer and their partners: a Delphi consensus study

Article References: Machielsen, A., Meijer, N., van Dongen, J., Boll, D., van Haren, E., Oonk, M., Aarts, J. A. W. M., Oerlemans, S., Kimman, M., van Esch, E., & Ezendam, N. (2026). Determining core quality of life outcomes for patients with vulvar cancer and their partners: a Delphi consensus study. Supportive Care in Cancer, 34(10), Article 1061. https://doi.org/10.1007/s00520-026-11270-0

Image Credits: AI Generated

DOI: 10.1007/s00520-026-11270-0

Keywords: vulvar cancer, core outcome set, quality of life, Delphi study, patient-reported outcomes, gynecologic oncology, sexual functioning, body image, fear of recurrence, EORTC questionnaires, supportive care, partners of cancer patients